Frequently Asked Questions relating to investing with ADVANZ PHARMA.
ADVANZ PHARMA’s limited voting shares were delisted from the Toronto Stock Exchange at close of trading on March 27, 2020. Following the delisting from the Toronto Stock Exchange, there is no stock exchange on which to trade the limited voting shares of the Company.
The CUSIP number for ADVANZ PHARMA limited voting shares is G01022105.
ADVANZ PHARMA’s transfer agents are TSX Trust Company (Canada) and Continental Stock Transfer & Trust Company (US). The contact information for TSX Trust is email: firstname.lastname@example.org and phone: 1 866 393-4891. The contact information for Continental is email: email@example.com and phone: 1 212 509-4000.
ADVANZ PHARMA’s fiscal year end is December 31.
The next annual shareholder meeting has not yet been scheduled.
PricewaterhouseCoopers LLP is
ADVANZ PHARMA’s external auditor, to hold office until the next annual meeting of shareholders.
Not at this time.